Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$11.69
+4.7%
$11.67
$9.30
$25.36
$542.39M1.12540,702 shs465,995 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$3.85
+8.1%
$2.72
$0.82
$3.94
$175.37M1.153.08 million shs5.48 million shs
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$31.43
+4.4%
$37.45
$21.77
$81.56
$465.48M1.34687,265 shs847,315 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.95
+0.1%
$13.80
$8.15
$19.00
$534.39M2.2287,268 shs313,527 shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-1.99%+1.75%-5.83%-9.50%-51.98%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
+7.55%+13.74%+40.71%+33.83%+242.31%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-3.56%-14.32%-25.11%-32.08%+2.49%
ZimVie Inc. stock logo
ZIMV
ZimVie
-0.16%+0.53%+1.07%+128.62%+9.61%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3.2356 of 5 stars
0.03.00.00.02.93.32.5
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
1.9186 of 5 stars
3.51.00.00.03.00.00.6
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
3.5446 of 5 stars
3.64.00.00.02.71.71.3
ZimVie Inc. stock logo
ZIMV
ZimVie
0.6895 of 5 stars
1.03.00.00.02.61.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.00
HoldN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00133.77% Upside
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
3.25
Buy$81.75160.10% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$17.75-6.33% Downside

Current Analyst Ratings Breakdown

Latest MBOT, ZIMV, AVNS, and SMLR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
8/6/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$61.00 ➝ $60.00
7/31/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$19.00
7/28/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$61.00
7/28/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$61.00
7/22/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$9.00 ➝ $19.00
7/9/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$95.00
7/8/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$101.00
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$692.50M0.78$12.18 per share0.96$16.73 per share0.70
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.67 per shareN/A
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$56.29M8.27$4.51 per share6.97$25.90 per share1.21
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.19$1.86 per share10.21$14.64 per share1.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$392.10M-$10.07N/A6.76N/A-66.89%6.16%4.57%10/29/2025 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$11.44M-$0.58N/AN/AN/AN/A-76.27%-67.54%N/A
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$40.90M$2.4312.93N/A86.20%43.84%32.88%11/3/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/A-4.39%6.37%3.34%10/29/2025 (Estimated)

Latest MBOT, ZIMV, AVNS, and SMLR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08-$0.10-$0.02-$0.10$1.00 millionN/A
8/5/2025Q2 2025
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.18$0.17-$0.01-$1.66$165.50 million$175.00 million
8/4/2025Q2 2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-$0.27$5.04+$5.31$5.04$8.10 million$8.22 million
7/30/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2080$0.26+$0.0520-$0.14$112.60 million$116.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.12
2.64
1.58
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
12.06
12.06
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
0.25
0.60
0.58
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
49.37%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.64%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
16.40%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2,22746.40 million45.18 millionOptionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2045.55 million43.39 millionOptionable
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
12014.81 million12.38 millionNot Optionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.20 million27.35 millionOptionable

Recent News About These Companies

ZimVie Board Unanimously Approves Transaction
ZimVie (NASDAQ:ZIMV) Sets New 12-Month High - What's Next?
ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings
ZimVie to sell to investment firm for about $730M

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Avanos Medical stock logo

Avanos Medical NYSE:AVNS

$11.69 +0.53 (+4.74%)
Closing price 03:59 PM Eastern
Extended Trading
$11.70 +0.02 (+0.14%)
As of 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$3.85 +0.29 (+8.15%)
Closing price 04:00 PM Eastern
Extended Trading
$3.96 +0.11 (+2.73%)
As of 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Semler Scientific stock logo

Semler Scientific NASDAQ:SMLR

$31.43 +1.33 (+4.42%)
Closing price 04:00 PM Eastern
Extended Trading
$31.59 +0.16 (+0.51%)
As of 06:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$18.95 +0.02 (+0.11%)
Closing price 04:00 PM Eastern
Extended Trading
$18.92 -0.03 (-0.15%)
As of 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.